[Reporter Hong's FoodToday] Medical staff and scholars from 30 countries around the world gathered... International collaborative organization 'IVRA' launched

[Food Today = Reporter Hong Seong-wook] As the novel coronavirus infection (COVID-19) pandemic continues, international cooperation to overcome COVID-19 has begun. The International Virus Research Alliance (IVRA), a joint collaboration centered on Korea and involving medical staff and scholars from over 30 countries around the world, was formed and began full-scale activities.

On the 29th, IVRA held the ‘International Conference on Sharing Hope Medical Care to Overcome the COVID-19 Pandemic’ at COEX and announced the launch of IVRA to the world.

Attending the conference on this day were Ambassador of Honduras to Korea, Ambassador to Korea of Sri Lanka, Commercial Attaché Claudia Fifea of Romania, Commercial Attaché Philip Winkler of Austria, Commercial Attaché Daniela Petrova of Bulgaria, Commercial Attaché Bwanga Kapumpa of Zambia, Commercial Attaché Ahmed Amawi of Egypt, Commercial Attaché Win Pa Pa Thu of Myanmar, and Commercial Attaché Jose MA.Jojie of the Philippines, Cambodian Commercial Affairs Director Khath Chen and others attended.

▲ Kim Jin-soo, advisory member of the International Virus Research Alliance, is being interviewed by Food Today

Advisory members include Dr. Park Woo-sung (Chairman of the Cancer Center Promotion Committee), former director of Dankook University Medical Center; Professor Jang Hong-seok of the Catholic University of Korea, Professor Hwang Seong-oh of Yonsei-Wonju University, Professor Kang Young-nam of the Catholic University of Korea, Professor Jeong Yun-jae of Chung-Ang Medical University, Professor Kim Ho-jung of Soonchunhyang University Medical School, Professor Lee Hyeong-min of Kyung Hee University Medical School, Bundang Jesaeng Hospital Center Director Kim Young-sik, Jeong Young-ho, Director of Jeong Internal Medicine,

Yonsei Line Clinic Director Ahn Seong-hwan, Director Shin Hyeong-jin of Pangyo Yonsei University Hospital, President Kim Kyeong-Jin of the Korean Association of Balance Medicine, former president Choi Nak-won of the Integrated Cancer Society, GBA Korea Chairman Oh Sinan Ozturk, Chairman Yoon Seok-Heon of the Asian Economic Development Committee, Former Food and Drug Administration Commissioner Kim Jin-soo, IND CEO Jang Chang-don, Eunseong Medical Foundation CEO Jeong Ho-jae, etc. A total of 50 medical experts and prominent figures were appointed.

On this day, Yang Seung-jo, Governor of Chungcheongnamdo Province, and Mohamed Jinna, Chairman of the United World Halal Development(UNWHD), delivered congratulatory remarks, and Korean and foreign medical and political figures from over 30 countries participated via online to congratulate the launch of IVRA and the holding of an international conference.
  

In particular, at this event, the results of treatment of COVID-19 patients using AdipoLABs' high-frequency hyperthermia cancer treatment device 'REMISSION 1℃' conducted by Professor Jang Hong-seok's team at Seoul St. Mary's Hospital and Seosan Medical Center were announced, attracting great attention.

We followed the conference that day.

Kim Jin-su, advisory member of the International Virus Research Alliance (Food Today editorial director):

-What kind of organization is the International Virus Research Alliance (IVRA)?

The International Virus Research Alliance (IVRA) is an organization of medical experts formed to exchange joint research results and information among members in order to solve each country's problems for the treatment of COVID-19 by collaborating with various countries to end the COVID-19 pandemic. .

-What will be introduced at today’s conference?

To treat COVID-19, a treatment was discovered by applying the principle that “Heat (hyperthermia) treatment is effective in viral infection.”
  

As a result of treatment of 20 patients, the average Ct value after treatment for the E gene was 32.63, the average value for the RdRP S gene was 33.18, and the average value for the N gene was 33.24. This result is evaluated as statistically significant.

▲ Source: NCBI<Repeated Coronavirus Disease 2019 Molecular Testing>

For reference, the Ct value presented by Korea's quarantine authorities is 35 to 40, which is the standard for dividing positive and negative, but considering that the global negative standard is 29.5 or less, all post-treatment results obtained in this clinical trial were above 32, which is significant. It is evaluated that there is.

In a situation where there is currently no cure, if treatment and research are carried out simultaneously by expanding this globally, it will be possible to eliminate the contagiousness of mild coronavirus patients and asymptomatic coronavirus positive people and allow them to return to life at an early stage.

- What role will the International Virus Research Alliance(IVRA) play in the future?

With Korea IVRA at the center, we plan to widely distribute this treatment to member countries and continue to conduct treatment and research. We also plan to provide high-frequency hyperthermia device used in treatment to IVRA member countries.

출처 : http://www.foodtoday.or.kr/news/article.html?no=167928